Marc Seaman

Marc Seaman has a diverse work experience in the biotechnology and clinical trial services industry. Marc is currently serving as the Director of Business Development - Clinical Trial Services at Versiti Inc., where they are responsible for identifying and pursuing new business opportunities in the clinical trial services market. Prior to this, they worked as the Director of Business Development at Medicus LIS from 2020 to 2022. Before that, they were the Manager of BioServices Project Management at Q2 Solutions from 2018 to 2020. In 2015, Marc served as the Vice President of Operations at Blue Ridge Biosciences, where they generated peptides for imaging, therapeutics, and biomarker discovery. Marc'scareer also includes a role as an Imaging Scientist and Study Director at inviCRO, LLC, where they managed and coordinated various preclinical studies for pharmaceutical, biotech, and academic clients.

Marc Seaman completed their Bachelor of Science degree in Biomedical Engineering at Georgia Institute of Technology from 2003 to 2007. Marc later pursued their Doctor of Philosophy (PhD) in Biomedical Engineering at the University of Virginia from 2008 to 2014.